ALKERMES | 판매 매출 총 이익

Gross Profit On Sales 변화 날짜
AbbVie USD 9.56B 95M 2023-09
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Amgen USD 5.08B 14M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Merck USD 11.29B 441M 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Otsuka Holdings JPY 374.05B 25.94B 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



ALKERMES 판매 매출 총 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.